510(k) Report

FDA applicant

Roche Molecular Systems, Inc.

Pleasanton, CA70 decisions1993–202616 recalls

FDA records 70 decisions for Roche Molecular Systems, Inc. (Pleasanton, CA) from 1993 to 2026: 52 510(k) clearances, 3 De Novo grants and 15 original PMA approvals. Most are in product codes QEP (Nucleic Acid Detection System For Non-Viral…) and MZP (Assay, Hybridization And/Or Nucleic Acid…). Since 2016 its 510(k)s took a median of 171 days from receipt to decision, against 175 for FDA’s reviews in the same codes and years. Its devices cite 61 predicates, 36 of them its own earlier devices. 16 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Roche Molecular Systems, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

11in 2025

2008: 22010: 12011: 22012: 22013: 12014: 22015: 52016: 22017: 32018: 22019: 32020: 42021: 52022: 32023: 32025: 112026 (partial year): 6
2007high 11 (2025) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2021

2007: 22011: 22012: 12013: 12014: 12016: 12017: 12020: 12021: 1
2007high 2 (2007) · low 0 (2008)2026

Class I Class II/III not classified

FIG. 1 — Roche Molecular Systems, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Roche Molecular Systems, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Roche”

FDA records each applicant name separately; these may or may not be the same firm.